Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
10:46am, Friday, 31'st Mar 2023
Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
08:48am, Friday, 31'st Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
11:05am, Wednesday, 29'th Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock
08:20am, Wednesday, 29'th Mar 2023
Demand for the company's COVID-19 vaccine could fall by significantly more than what investors were expecting. Revenue this year could top $5 billion, but in 2024 it may be much lower than that.
2 Nasdaq 100 Stocks to Buy Hand Over Fist Right Now
09:37am, Tuesday, 28'th Mar 2023
Your portfolio needs to have stocks that'll expose it to long-term growth. Moderna's shares are selling on the cheap right now, and its growth runway is long.
Could CRISPR Therapeutics Become the Next Moderna?
06:00am, Monday, 27'th Mar 2023
CRISPR has some important elements in common with vaccine giant Moderna. And the company is heading for an important moment in its growth story.
3 Things About Moderna That Smart Investors Know
06:00am, Saturday, 25'th Mar 2023
Moderna's post-pandemic vaccine sales aren't likely to reach the levels we've seen during the height of the pandemic. Now, the company is preparing for its next phase of growth.
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio
04:46pm, Friday, 24'th Mar 2023
Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
7 Blue-Chip Stocks Sitting in the Sweet Spot
01:56pm, Thursday, 23'rd Mar 2023
Although blue-chip stocks often carry a reputation for being lumbering giants that might not kill your portfolio but certainly won't do it any favors, specific stalwarts can get the business done. In
Why Moderna wants to raise the cost of its COVID-19 vaccine
12:00pm, Thursday, 23'rd Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss key takeaways from Moderna CEO Stéphane Bancel's testimony before the Senate and why the pharmaceutical biotechnology company wants to
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
10:20am, Thursday, 23'rd Mar 2023 Zacks Investment Research
Sector ETF report for FBT
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
10:20am, Thursday, 23'rd Mar 2023 Zacks Investment Research
Sector ETF report for RYH
Generation Bio, Moderna announce collaboration
07:44am, Thursday, 23'rd Mar 2023
Shares of Generation Bio Co. GBIO, -0.51% jumped about 28% premarket trading on Thursday after the company announced a collaboration with Moderna Inc. MRNA, -2.58% to to develop novel nucleic acid the
Moderna plans 400% increase in price of Covid vaccine
08:10pm, Wednesday, 22'nd Mar 2023
Public Citizen Access to Medicines Director Peter Maybarduk and Northwestern healthcare economist Craig Garthwaite joins CNBC's Brian Sullivan and ‘Last Call' to discuss the debate over Moderna's de
